[144] Natera, Inc. SEC Filing

Rhea-AI Filing Summary

Natera, Inc. (NTRA) Form 144 filed to report a proposed sale of 9,210 shares of common stock through Charles Schwab & Co., Inc., with an aggregate market value reported as $1,620,445.00 and an approximate sale date of 09/17/2025 on NASDAQ. The filer indicates the shares were acquired on 04/12/2021 from the issuer by various methods and dates. The filing also discloses multiple prior small sales by the same person during the past three months: sales on 07/02/2025, 07/16/2025, 08/08/2025, and 08/11/2025 totaling reported gross proceeds shown per sale.

Positive

• Filing compliance: The Form 144 includes required elements (broker, number of shares, aggregate market value, acquisition date) demonstrating regulatory disclosure.
• Transparency on recent sales: The form lists multiple past three-month sales with dates and gross proceeds, aiding market transparency.

Negative

• Insider liquidity event: Proposed sale of 9,210 shares valued at $1,620,445.00 could be viewed negatively by some investors monitoring insider sales.
• Repeated disposals: Four separate sales in July–August 2025 are disclosed, indicating ongoing reduction of holdings by the reporting person.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 notice reporting proposed sale of 9,210 NTRA shares valued at about $1.62M; appears compliant.

The filing is a standard Rule 144 disclosure notifying the market of an intended restricted/affiliate sale executed through Charles Schwab on NASDAQ. It specifies acquisition date (04/12/2021) and shows prior disposals in the past three months, which helps satisfy aggregation and reporting requirements. The notice includes the required representation about absence of undisclosed material adverse information and the signature warning, aligning with procedural compliance expectations. From a compliance standpoint, the document contains the essential elements needed for a Rule 144 notice.

Equity Capital Markets Specialist

TL;DR: Insider selling activity of several transactions is disclosed; impact on float is limited but worth noting.

The scheduled sale of 9,210 shares with an aggregate market value reported at $1,620,445.00 represents a disclosed disposition by a person associated with the issuer. The filing further lists four recent sales during July and August 2025, indicating ongoing monetization of holdings. While the absolute dollar value is modest relative to large-cap floats, the disclosure is material for market transparency and for shareholders monitoring insider activity. The document does not provide any explanation for the sales beyond the procedural statements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	9210	1620445.00	137248106	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	04/12/2021	VARIOUS METHODS & DATES	ISSUER			9210	04/12/2021	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan Sheena C/O 13011 McCallen Pass, Building A Suit 100 Austin TX 78753	COMMON	07/02/2025	3000	480309.00
JONATHAN SHEENA C/O 13011 McCallen Pass Building A Suite 100 Austin TX 78753	COMMON	07/16/2025	3070	460387.00
JONATHAN SHEENA C/O 13011 McCallen Pass Building A Suite 100 Austin TX 78753	COMMON	08/08/2025	3070	497047.00
JONATHAN SHEENA C/O 13011 McCallen Pass Building A Suite 100 Austin TX 78753	COMMON	08/11/2025	3000	461012.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this NTRA Form 144 filing disclose?

The filing reports a proposed sale of 9,210 NTRA common shares through Charles Schwab with an aggregate market value of $1,620,445.00 and lists prior sales in July and August 2025.

Who is acting as broker for the reported sale?

The broker listed for the proposed sale is Charles Schwab & Co., Inc.

When were the shares being sold originally acquired?

The securities to be sold were acquired on 04/12/2021, described as obtained by various methods from the issuer.

Does the filing indicate any undisclosed material information about Natera (NTRA)?

The signer represents they do not know any material adverse information not publicly disclosed; the filing itself does not state any undisclosed material facts.

What recent sales by the same person are reported in the filing?

The filing lists sales on 07/02/2025, 07/16/2025, 08/08/2025, and 08/11/2025 with gross proceeds shown for each transaction.